Community post

Sandra Morales and Paul Hyman have published a new perspective called "Quis Custodiet? Are Regulations Slowing Phage Therapy?".  In it, they discuss current regulations, recent efficacy trials and support resources in the context of regulatory approval of phage therapy for widespread use.